Paroxysmal supraventricular tachycardia historical perspective

Revision as of 00:16, 13 July 2020 by Noha Elzeiny (talk | contribs)
Jump to navigation Jump to search

Paroxysmal supraventricular tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paroxysmal supraventricular tachycardia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Paroxysmal supraventricular tachycardia historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paroxysmal supraventricular tachycardia historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paroxysmal supraventricular tachycardia historical perspective

CDC on Paroxysmal supraventricular tachycardia historical perspective

Paroxysmal supraventricular tachycardia historical perspective in the news

Blogs on Paroxysmal supraventricular tachycardia historical perspective

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Paroxysmal supraventricular tachycardia historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Noha Elzeiny, M.B.B.Ch, M.Sc.[2]

Overview

Historical Perspective

  • There is limited information about the historical perspective of PSVT.
  • In January 1998 the first epidemiologic study of the general population in USA was published [1].
  • Catheter-based radiofrequency ablation has improved the treatment of PSVT by precise ablation of the abnormal accessory pathway.  First catheter ablations were in the early to mid-1980s, since then it has improved progressively especially in terms of safety and specificity [2].

References

  1. Orejarena, L. A., Vidaillet, H., DeStefano, F., Nordstrom, D. L., Vierkant, R. A., Smith, P. N., & Hayes, J. J. (1998). Paroxysmal Supraventricular Tachycardia in the General Population. Journal of the American College of Cardiology, 31(1), 150–157. doi:10.1016/s0735
  2. Ghzally Y, Gerasimon G. Catheter Ablation. [Updated 2020 Feb 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470203/


Template:WH Template:WS